For the dual trial, the quantitative results of β-HCG and blood PAPP-A, combined with ultrasound results such as nuchal translucency (NT), rumpback length (CRL) will be converted to the multiple center MoM in the week of the clothes, calculating the risk value of disease for each fetus according to the possible rate of determination.